Earnings call transcript: Vikram Solar Q1 2027 revenue jumps, margin pressure weighs

Vikram Solar’s Q1 FY2027 revenue rose 38% YoY to INR 1,560 crores on record dispatches of 1,006 MW (up 32% YoY), but EBITDA fell to INR 126 crores, with the EBITDA margin compressing to 8.06%. Management attributed the margin hit to war-related inflation in metals (aluminum/copper), crude-linked EVA costs, and elevated cell prices amid industry oversupply, while guidance remained limited due to ongoing ALMM2 policy uncertainty (deferred to Dec 2026). The stock dropped 5.53% to $164.34, as investors weighed strong volume growth against weaker profitability and no firmer full-year margin outlook.

Analysis

This reads like a classic transition quarter where the equity is trading on the wrong variable. The near-term earnings power is being squeezed by the part of the cost stack management cannot fully reprice in real time, so the market is effectively discounting a prolonged margin reset rather than a temporary input shock. What matters for the next 1-3 months is not volume growth, but whether the company can prove that the mix shift toward higher-ticket channels actually offsets commodity and inventory drag before the next print.

Second-order, the policy backdrop is creating a bifurcation inside Indian solar manufacturing: integrated players with cell/wafer control should regain pricing and working-capital leverage, while module assemblers without captive upstream capacity risk being forced into a race to the bottom. That also means the downstream distribution channel may be a short-lived margin bridge, not a durable moat; once more domestic cell supply comes online, gross margin could normalize but not necessarily to prior peak levels if the industry remains oversupplied. The bigger risk is that capex intensity rises faster than operating cash flow, turning a potential integration story into an ROCE and dilution story.

Contrarian take: the market may be overreacting to one weak quarter, but underreacting to execution timing. If the cell ramp slips or policy support gets extended again, the “backward integration premium” can disappear while leverage inches up. Conversely, if management can hold margins near current levels until the cell plant contributes, the stock could rerate sharply because the current multiple already prices in a damaged business, not a future integrated platform.

Key Decisions for Investors

• Avoid chasing the equity on the first bounce; use any 1-3 month relief rally to stay underweight until the next quarter confirms whether EBITDA margin can stabilize above the high-single-digit trough.
• Pair trade over 6-12 months: long integrated Indian solar manufacturers with captive cell/wafer exposure, short module-only assemblers that still rely on external cells and have less pricing power.
• Set a catalyst watch on the next quarterly update: if management cannot show sequential improvement in gross margin or a firmer FY27 guidance range, treat the recovery thesis as broken and keep a bearish bias.
• If you want exposure to the policy-driven demand theme, prefer downstream installers/EPCs over module manufacturers; the former should benefit from lower panel prices without bearing the same inventory and commodity risk.